Clinical Trial
Therapy for hepatocellular cancer with intrahepatic arterial adriamycin and 5-fluorouracil combined with whole-liver irradiation: a Northern California Oncology Group Study
- PMID: 230895
Item in Clipboard
Clinical Trial
Therapy for hepatocellular cancer with intrahepatic arterial adriamycin and 5-fluorouracil combined with whole-liver irradiation: a Northern California Oncology Group Study
Cancer Treat Rep.
1979 Nov-Dec.
Abstract
Thirteen patients with hepatocellular cancer were treated with intrahepatic arterial Adriamycin and 5-fluorouracil combined with whole-liver irradiation. Six patients (46%) had an objective regression and five (38%) had stable disease. Symptomatic improvement was noted in 81% of the patients. The minimum median survival time was 5.0 months for those patients who responded. Toxicity was acceptable. This is an effective combination for the treatment of this especially aggressive and intractable form of cancer.
Similar articles
-
Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.Am J Clin Oncol. 2003 Aug;26(4):e92-9. doi: 10.1097/01.COC.0000077936.97997.AB. Am J Clin Oncol. 2003. PMID: 12902905 Clinical Trial.
-
Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies.J Clin Oncol. 2005 Dec 1;23(34):8739-47. doi: 10.1200/JCO.2005.01.5354. J Clin Oncol. 2005. PMID: 16314634 Clinical Trial.
-
Phase III trial of irradiation plus chemotherapy for patients with hepatic metastases and hepatoma: experience of the Northern California Oncology Group.NCI Monogr. 1988;(6):259-64. NCI Monogr. 1988. PMID: 2832763 Clinical Trial.
-
Update on regional treatments for hepatobiliary malignancies.Gan To Kagaku Ryoho. 1995 Sep;22(11):1437-52. Gan To Kagaku Ryoho. 1995. PMID: 7574729 Review. No abstract available.
-
Hepatic artery ligation and adriamycin infusion chemotherapy for hepatoma.Cancer. 1978 Apr;41(4):1249-55. doi: 10.1002/1097-0142(197804)41:4<1249::aid-cncr2820410405>3.0.co;2-q. Cancer. 1978. PMID: 205338 Review.
Cited by
-
Hepatic arterial chemotherapy for primary and metastatic liver cancers.Cancer Chemother Pharmacol. 1989;23 Suppl:S68-73. doi: 10.1007/BF00647244. Cancer Chemother Pharmacol. 1989. PMID: 2647314 Review.
-
Primary hepatocellular carcinoma. Present state of the disease and prospects for the future.Cancer Chemother Pharmacol. 1982;8(2):231-5. doi: 10.1007/BF00255489. Cancer Chemother Pharmacol. 1982. PMID: 6286165 Review.
-
Transcatheter arterial chemoembolization: history for more than 30 years.ISRN Gastroenterol. 2012;2012:480650. doi: 10.5402/2012/480650. Epub 2012 Aug 26. ISRN Gastroenterol. 2012. PMID: 22966466 Free PMC article.
-
Challenge and hope in radiotherapy of hepatocellular carcinoma.Yonsei Med J. 2009 Oct 31;50(5):601-12. doi: 10.3349/ymj.2009.50.5.601. Epub 2009 Oct 20. Yonsei Med J. 2009. PMID: 19881961 Free PMC article. Review.
-
Hepatoma.West J Med. 1980 Jun;132(6):514-20. West J Med. 1980. PMID: 6250289 Free PMC article. No abstract available.